Greater Cannabis Company (GCAN) Gross Profit Growth (1y) (2018 - 2021)

Greater Cannabis Company (GCAN) Gross Profit Growth (1y) (2018 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 5.06%
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 2.59%
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -18.38%
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -7.66%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -0.34%
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 42.12%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 14.77%
10 Greater Cannabis Company 236,233.75 234,794.75 - -

Historic Data

Download Data
DateValue
Jun 30, 2021 45.65%
Jun 30, 2018 46,520.00%